Quantifying the Tolerability of Dopamine Agonist Antiparkinsonian Medication Side Effects: A Best-Worst Scaling Survey

Richards K, Avanceña ALV, Johnsrud M, Collier H, Mantri S, Yarbrough D, Subasinghe A, Sasané R, Arcona S

Patient Preference and Adherence 2026, 20:570840

Published Date: 24 February 2026